Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 105.9 | 54.3 | 21.4 | 32.4 | 0.0 | 0.0 |
| Revenue growth | 95.2% | 153.7% | -34.0% | | | |
| Cost of goods sold | 47.8 | 24.4 | 0.0 | 15.8 | 0.0 | 0.0 |
| Gross profit | 58.1 | 29.9 | 21.4 | 16.6 | 0.0 | 0.0 |
| Gross margin | 54.9% | 55.1% | 100.0% | 51.2% | | |
| Selling, general and administrative | 116.6 | 118.5 | 50.3 | 10.1 | 17,160.8 | 19,024.2 |
| Research and development | 2.3 | 8.8 | 8.5 | 5.7 | 9,945.0 | 11,866.6 |
| EBIT | -60.8 | -97.5 | -37.5 | 16.6 | -16,632.7 | 0.0 |
| EBIT margin | -57.4% | -179.6% | -175.1% | 51.2% | | |
| Pre-tax income | -122.8 | -103.0 | -37.6 | 19.7 | -16,708.3 | 0.0 |
| Income taxes | 2.4 | -0.1 | 0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.1% | | 0.0% | 0.0% | |
| Net income | -125.2 | -103.0 | -37.8 | 19.7 | -16,708.3 | -25,283.0 |
| Net margin | -118.2% | -189.8% | -176.6% | 60.7% | | |
| |
| Diluted EPS | ($1.89) | ($1.66) | ($1.16) | $0.60 | ($0.55) | ($0.84) |
| Shares outstanding (diluted) | 66.4 | 61.9 | 32.6 | 32.8 | 30,449.7 | 30,092.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|